Ignite Creation Date:
2025-12-24 @ 5:19 PM
Ignite Modification Date:
2026-02-01 @ 1:25 PM
Study NCT ID:
NCT06253650
Status:
RECRUITING
Last Update Posted:
2024-06-13
First Post:
2024-02-02
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Adjuvant TRastuzumab Deruxtecan for HER2-positive Gastroesophageal Cancer With Persistence of miNImal Residual Disease
Sponsor:
Organization: